| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |